It is possible that these properties result from the ability of Sigma1R to exhibit different affinity to the ligand depending on the homomeric structure of the chaperone [383,384,385,386], which may vary in the dynamics of neurodegenerative diseases’ pathogenesis. The gene discussed is SIGMAR1; the disease is neurodegenerative disease.